RCKT Earnings

Quarterly EPS
$-0.71
Q3 2024
$-0.62
Q4 2024
$-0.56
Q1 2025
$-0.62
Q2 2025
$-0.45
Q3 2025
$-0.38
Q4 2025
$-0.42
Q1 2026
$1.09
Q2 2026
Latest RevenueN/A
Latest Net Income123.2M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.090123.2M+275.8%
Q1 2026-$0.420-48823000+25.0%
Q4 2025-$0.380-42538000+38.7%
Q3 2025-$0.450-50332000+36.6%
Q2 2025-$0.620-68919000+16.2%
Q1 2025-$0.560-63524000+15.2%
Q4 2024-$0.620-60327000+3.1%
Q3 2024-$0.710-66719000+5.3%
Q2 2024-$0.740-69646000
Q1 2024-$0.660-62054000
Q4 2023-$0.640-59660000
Q3 2023-$0.750-61899000
Rocket Pharmaceuticals (RCKT) — Earnings